Skip to content

Clinical trials

Phase 3 Arthritis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis Phase: Phase 3 Country / region: Germany Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20081
20098
20105
20112
20121
20131
20143
20155
20163
20173
20181
20191
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Active, not recruiting2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Amgen7
AbbVie6
Eli Lilly and Company3
Pfizer3
Fujifilm Kyowa Kirin Biologics Co., Ltd.2
Regeneron Pharmaceuticals2
UCB Biopharma SRL2
AbbVie (prior sponsor, Abbott)1
Charite University, Berlin, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis39
Arthritis, Rheumatoid13
Joint Diseases10
Musculoskeletal Diseases9
Arthritis, Juvenile8
Arthritis, Psoriatic8
Psoriasis5
Rheumatic Diseases5
Gout4
Inflammation3

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.